The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Kerr, Paul Gerard, Dr
    Ceo born in February 1972
    Individual (3 offsprings)
    Officer
    2021-07-28 ~ now
    OF - Director → CIF 0
  • 2
    Scott, Christopher John, Prof
    Director born in August 1974
    Individual (1 offspring)
    Officer
    2023-01-01 ~ now
    OF - Director → CIF 0
  • 3
    Johnston, James Anthony, Prof
    Director born in November 1961
    Individual (1 offspring)
    Officer
    2023-01-01 ~ now
    OF - Director → CIF 0
  • 4
    Moore, David
    Investment Manager born in July 1963
    Individual (21 offsprings)
    Officer
    2021-07-28 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

AILSEBIO LIMITED

Previous name
AILSEVAX LIMITED - 2025-03-13
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Average Number of Employees
52023-01-01 ~ 2023-12-31
42021-07-28 ~ 2022-12-31
Intangible Assets
10,451 GBP2023-12-31
393 GBP2022-12-31
Property, Plant & Equipment
20,792 GBP2023-12-31
3,698 GBP2022-12-31
Fixed Assets
31,243 GBP2023-12-31
4,091 GBP2022-12-31
Debtors
Current
125,092 GBP2023-12-31
844,226 GBP2022-12-31
Cash at bank and in hand
568,353 GBP2023-12-31
37,079 GBP2022-12-31
Current Assets
693,445 GBP2023-12-31
881,305 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-48,048 GBP2023-12-31
-42,555 GBP2022-12-31
Net Current Assets/Liabilities
645,397 GBP2023-12-31
838,750 GBP2022-12-31
Total Assets Less Current Liabilities
676,640 GBP2023-12-31
842,841 GBP2022-12-31
Net Assets/Liabilities
676,640 GBP2023-12-31
842,841 GBP2022-12-31
Equity
Called up share capital
798 GBP2023-12-31
798 GBP2022-12-31
Share premium
937,047 GBP2023-12-31
937,047 GBP2022-12-31
Retained earnings (accumulated losses)
-261,205 GBP2023-12-31
-95,004 GBP2022-12-31
Equity
676,640 GBP2023-12-31
842,841 GBP2022-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
10,996 GBP2023-12-31
414 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
545 GBP2023-12-31
21 GBP2022-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
10,451 GBP2023-12-31
393 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Computers
27,011 GBP2023-12-31
3,916 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Computers
218 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers, Owned/Freehold
6,001 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
6,219 GBP2023-12-31
Property, Plant & Equipment
Computers
20,792 GBP2023-12-31
3,698 GBP2022-12-31
Other Debtors
Current
96,013 GBP2023-12-31
6,536 GBP2022-12-31
Called-up share capital (not paid)
Current
837,690 GBP2022-12-31
Prepayments/Accrued Income
Current
29,079 GBP2023-12-31
Cash and Cash Equivalents
568,353 GBP2023-12-31
37,079 GBP2022-12-31
Trade Creditors/Trade Payables
Current
31,341 GBP2023-12-31
28,672 GBP2022-12-31
Taxation/Social Security Payable
Current
9,733 GBP2023-12-31
466 GBP2022-12-31
Other Creditors
Current
1,774 GBP2023-12-31
1,349 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
5,200 GBP2023-12-31
12,068 GBP2022-12-31
Creditors
Current
48,048 GBP2023-12-31
42,555 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
79,804 shares2023-12-31
79,804 shares2022-12-31
Par Value of Share
Class 1 ordinary share
0.012023-01-01 ~ 2023-12-31

  • AILSEBIO LIMITED
    Info
    AILSEVAX LIMITED - 2025-03-13
    Registered number NI681133
    C/o Qubis Ltd, 63 University Road, Belfast BT7 1NF
    Private Limited Company incorporated on 2021-07-28 (3 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-25
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.